Genesee Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$226K Buy
+535
New +$213K 0.07% 168
2024
Q2
– Sell
-3,456
Closed -$983K – 127
2024
Q1
$983K Sell
3,456
-69
-2% -$20.2K 0.54% 45
2023
Q4
$1.02M Buy
+3,525
New +$960K 0.63% 41
2020
Q4
– Sell
-3,470
Closed -$881K – 85
2020
Q3
$881K Buy
3,470
+27
+0.8% +$6.69K 0.73% 45
2020
Q2
$812K Sell
3,443
-364
-10% -$83K 0.76% 43
2020
Q1
$771K Buy
+3,807
New +$832K 0.74% 45

Other funds holding AMGN

Genesee Capital Advisors's AMGN Position: Q3 2026 in Review

Genesee Capital Advisors opened a new position in Amgen (AMGN) in Q3 2026: 535 shares worth $226K. The stake represents 0.07% of the portfolio and ranks #168 among its holdings. This is a return to the name: Genesee Capital Advisors previously reported a position in AMGN as recently as Q1 2024.

Genesee Capital Advisors first reported a position in AMGN in Q1 2020 and has held it in 6 quarters since. The position peaked at $1.02M in Q4 2023. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Genesee Capital Advisors held 535 shares of Amgen worth $226K as of Q3 2026.
  • Amgen was a new Genesee Capital Advisors position in Q3 2026.
  • Amgen made up 0.07% of Genesee Capital Advisors's portfolio in Q3 2026, its #168 holding.
  • Genesee Capital Advisors first reported a position in Amgen in Q1 2020 and has held it in 6 quarters since.
  • Genesee Capital Advisors's Amgen position peaked at $1.02M in Q4 2023.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Genesee Capital Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.